Iontophoretically enhanced ciclopirox delivery into and across human nail plate

Journal of Pharmaceutical Sciences

Volumn 98, Issue 10, 2009, Pages 3608-3616

  Hao, Jinsong ^a   Smith, Kelly A ^a   Li, S Kevin ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Ciclopirox; Constant voltage; Human nail plate; Iontophoresis; Transungual delivery

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE;

ARTICLE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; IN VITRO STUDY; IONTOPHORESIS; MALE; MINIMUM INHIBITORY CONCENTRATION; NAIL;

EID: 67349218515     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21664     Document Type: Article

References (34)

1. Murdan S. 2007. 1st meeting on topical drug delivery to the nail. Expert Opin Drug Deliv 4:453-455. (Pubitemid 47249142)
2. Piraccini BM, Iorizzo M, Antonucci A, Tosti A. 2004. Treatment of nail disorders. Therapy 1:159-167.
3. Drake LA, Patrick DL, Fleckman P, Andr J, Baran R, Haneke E, Sapede C, Tosti A. 1999. The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 41:189-196. (Pubitemid 29379702)
4. Ajit C, Suvannasankha A, Zaeri N, Munoz SJ. 2003. Terbinafine-associated hepatotoxicity. Am J Med Sci 325:292-295.
5. Bohn M, Kraemer KT. 2000. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. J Am Acad Dermatol 43:S57-S69. (Pubitemid 30783041)
6. Gupta AK, Fleckman P, Baran R. 2000. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol 43:S70-S80. (Pubitemid 30783042)
7. Finch JJ, Warshaw EM. 2007. Toenail onychomycosis: Current and future treatment options. Dermatol Ther 20:31-46. (Pubitemid 46568375)
8. Rodgers P, Bassler M. 2001. Treating onychomycosis. Am Fam Physician 63:663-672.
9. Neubert RH, Gensbugel C, Jackel A, Wartewig S. 2006. Different physicochemical properties of anti-mycotic agents are relevant for penetration into and through human nails. Pharmazie 61:604-607. (Pubitemid 44098027)
10. Kobayashi Y, Komatsu T, Sumi M, Numajiri S, Miyamoto M, Kobayashi D, Sugibayashi K, Morimoto Y. 2004. In vitro permeation of several drugs through the human nail plate: Relationship between physicochemical properties and nail permeability of drugs. Eur J Pharm Sci 21:471-477.
11. Hui X, Baker SJ, Wester RC, Barbadillo S, Cashmore AK, Sanders V, Hold KM, Akama T, Zhang YK, Plattner JJ, Maibach HI. 2007. In vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate. J Pharm Sci 96:2622-2631.
12. Hui X, Chan TC, Barbadillo S, Lee C, Maibach HI, Wester RC. 2003. Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane. J Pharm Sci 92:142-148. (Pubitemid 36042305)
13. Khengar RH, Jones SA, Turner RB, Forbes B, Brown MB. 2007. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers. Pharm Res 24:2207-2212. (Pubitemid 350064249)
14. Murdan S. 2002. Drug delivery to the nail following topical application. Int J Pharm 236:1-26. (Pubitemid 34219369)
15. Hui X, Wester RC, Barbadillo S, Lee C, Patel B, Wortzmman M, Gans EH, Maibach HI. 2004. Ciclopirox delivery into the human nail plate. J Pharm Sci 93:2545-2548. (Pubitemid 39319437)
16. Monti D, Saccomani L, Chetoni P, Burgalassi S, Saettone MF, Mailland F. 2005. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer. Drug Dev Ind Pharm 31:11-17.
17. Kalinowski DP, Edsberg LE, Hewson RA, Johnson RH, Brogan MS. 2004. Low-voltage direct current as a fungicidal agent for treating onychomycosis. J Am Podiatr Med Assoc 94:565-572.
18. Kasting GB. 1992. Theoretical models for iontophoretic delivery. Adv Drug Deliv Rev 9:177-199.
19. Pikal MJ. 1992. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 9:201-237.
20. Chizmadzhev YA, Indenbom AV, Kuzmin PI, Galichenko SV, Weaver JC, Potts RO. 1998. Electrical properties of skin at moderate voltages: Contribution of appendageal macropores. Biophys J 74:843-856. (Pubitemid 28345278)
21. Glaser RW, Leikin SL, Chernomordik LV, Pastushenko VF, Sokirko AI. 1988. Reversible electrical breakdown of lipid bilayers: Formation and evolution of pores. Biochim Biophys Acta 940:275-287.
22. James MP, Graham RM, English J. 1986. Percutaneous iontophoresis of prednisolone - A pharmacokinetic study. Clin Exp Dermatol 11:54-61. (Pubitemid 16201375)
23. Murthy SN, Wiskirchen DE, Bowers CP. 2007. Iontophoretic drug delivery across human nail. J Pharm Sci 96:305-311. (Pubitemid 46363561)
24. Murthy SN, Waddell DC, Shivakumar HN, Balaji A, Bowers CP. 2007. Iontophoretic permselective property of human nail. J Dermatol Sci 46:150-152. (Pubitemid 46467285)
25. Hao J, Li SK. 2008. Transungual iontophoretic transport of polar neutral and positively charged model permeants: Effects of electrophoresis and electroosmosis. J Pharm Sci 97:893-905. (Pubitemid 351293889)
26. Hao J, Li SK. 2008. Mechanistic study of electroosmotic transport across hydrated nail plates: Effects of pH and ionic strength. J Pharm Sci 97:5186-5197.
27. Hao J, Smith KA, Li SK. 2008. Chemical method to enhance transungual transport and iontophoresis efficiency. Int J Pharm 357:61-69.
28. Gunt HB, Miller MA, Kasting GB. 2007. Water diffusivity in human nail plate. J Pharm Sci 96:3352-3362.
29. Jemec GB, Agner T, Serup J. 1989. Transonychial water loss: Relation to sex, age and nail-plate thickness. Br J Dermatol 121:443-446. (Pubitemid 19251471)
30. Nuutinen J, Harvima I, Lahtinen MR, Lahtinen T. 2003. Water loss through the lip, nail, eyelid skin, scalp skin and axillary skin measured with a closed-chamber evaporation principle. Br J Dermatol 148:839-841. (Pubitemid 36629781)
31. Murdan S, Hinsu D, Guimier M. 2008. A few aspects of transonychial water loss (TOWL): Inter-individual, and intra-individual inter-finger, inter-hand and inter-day variabilities, and the influence of nail plate hydration, filing and varnish. Eur J Pharm Biopharm 70:684-689.
32. Challapalli PV, Stinchcomb AL. 2002. In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation. Int J Pharm 241:329-339.
33. Gunt HB, Kasting GB. 2007. Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur J Pharm Sci 32:254-260.
34. Gupta AK. 2001. Ciclopirox: An overview. Int J Dermatol 40:305-310.